ProAxsis is delighted to announce that Dr Kelly Moffitt has joined the company in the role of Senior Project Manager, and will report in to the CEO, Dr David Ribeiro. Dr Moffitt worked in a number of research roles at Queen’s University, Belfast, prior to successfully obtaining a PRINCE2 Practitioner qualification in project management. This included a three-year period, working on a collaborative US-Ireland Cystic Fibrosis project with Professor Stuart Elborn. In her new role, she will be responsible for leading a number of R&D and commercial projects, which will be critical to the ongoing success of the company.
Dr David Ribeiro, CEO of ProAxsis, said: “Kelly was part of the team at Queens that originally came up with the idea of developing an assay for measuring the active form of neutrophil elastase in sputum from patients with chronic respiratory diseases such as cystic fibrosis and COPD. To attract someone of Kelly’s specific experience and knowhow to join us is a significant boost for the company.”
ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies. The company is also supported by QUBIS, the commercialisation arm of Queens University.